Jushi Holdings (JUSHF) Notes Payables (2023 - 2026)

Jushi Holdings' (JUSHF) quarterly Notes Payables came in at $139000.0 in Q1 2026, down 53.04% on a QoQ basis from $296000.0 in Q4 2025.

Jushi Holdings (JUSHF) Notes Payables (2023 - 2026) Analysis & Trends

Jushi Holdings (JUSHF) has 4 years of Notes Payables data on file, last reported at $139000.0 in Q1 2026.

  • On a quarterly basis, Notes Payables changed N/A year-over-year to $139000.0 in Q1 2026; TTM through Mar 2026 was $139000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $296000.0, changed N/A from the prior year.
  • Notes Payables for Q1 2026 stood at $139000.0, down from $296000.0 in the prior quarter.
  • Over the last five years, Notes Payables for JUSHF reached as high as $7.2 million in Q1 2024 and fell as low as $139000.0 in Q1 2026.
  • Historically, Notes Payables has averaged $2.1 million across 4 years, with a median of $1.2 million in 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Jushi Holdings 81.25 Mn 41.54 Mn 29.88 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 139,000.00
Dec 31, 2025 296,000.00
Sep 30, 2024 156,000.00
Jun 30, 2024 2.08 Mn
Mar 31, 2024 7.22 Mn
Dec 31, 2023 2.42 Mn